Cohance Lifesciences Limited
COHANCE
Rang in Aktien
#6487
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aktienkurs
$4.80
Marktkapitalisierung
$1.84B
Veränderung (1 Tag)
-5.65%
Veränderung (1 Jahr)
-59.50%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategorie
Healthcare
Kursverlauf für Cohance Lifesciences Limited (COHANCE)
Höchster Schlusskurs: $12.03 am 2025-06-01
Niedrigster Schlusskurs: $1.65 am 2020-03-01
Niedrigster Schlusskurs: $1.65 am 2020-03-01
Kursverlauf der Aktie von Cohance Lifesciences Limited von 2020 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2025 | -17.24% |
| 2024 | 75.72% |
| 2023 | 43.40% |
| 2022 | -12.41% |
| 2021 | 15.53% |
| 2020 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
